Youssry I - Search Results

1

Prevalence of α-Thalassemia in the Egyptian Population.

Youssry I, El Badawy A, Samy RM, Salama N, Abd Elaziz D, Rizk S. Youssry I, et al. Hemoglobin. 2018 Jul;42(4):243-246. doi: 10.1080/03630269.2018.1527231. Epub 2018 Nov 13. Hemoglobin. 2018. PMID: 30422721

2

Skin iron concentration: a simple, highly sensitive method for iron stores evaluation in thalassemia patients.

Youssry I, Mohsen NA, Shaker OG, El-Hennawy A, Fawzy R, Abu-Zeid NM, El-Beshlawy A. Youssry I, et al. Hemoglobin. 2007;31(3):357-65. doi: 10.1080/03630260701503833. Hemoglobin. 2007. PMID: 17654073

3

Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.

El-Beshlawy A, Manz C, Naja M, Eltagui M, Tarabishi C, Youssry I, Sobh H, Hamdy M, Sharaf I, Mostafa A, Shaker O, Hoffbrand AV, Taher A. El-Beshlawy A, et al. Among authors: youssry i. Ann Hematol. 2008 Jul;87(7):545-50. doi: 10.1007/s00277-008-0471-2. Epub 2008 Mar 20. Ann Hematol. 2008. PMID: 18351337 Clinical Trial.

4

Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.

El-Beshlawy A, Mostafa A, Youssry I, Gabr H, Mansour IM, El-Tablawy M, Aziz M, Hussein IR. El-Beshlawy A, et al. Among authors: youssry i. J Pediatr Hematol Oncol. 2008 Apr;30(4):281-4. doi: 10.1097/MPH.0b013e3181639afe. J Pediatr Hematol Oncol. 2008. PMID: 18391696

5

Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.

Hafez M, Youssry I, El-Hamed FA, Ibrahim A. Hafez M, et al. Among authors: youssry i. Hemoglobin. 2009;33(2):101-8. doi: 10.1080/03630260902817131. Hemoglobin. 2009. PMID: 19373585

6

Prevention of hemoglobinopathies in Egypt.

El-Beshlawy A, Youssry I. El-Beshlawy A, et al. Among authors: youssry i. Hemoglobin. 2009;33 Suppl 1:S14-20. doi: 10.3109/03630260903346395. Hemoglobin. 2009. PMID: 20001619

7

Genetic polymorphisms of glutathione-S-transferase and microsomal epoxide hydrolase in egyptian acquired aplastic anemia patients.

Youssry I, Hammoud R, Ibrahim O, Youssef M, Beshlawy A. Youssry I, et al. J Pediatr Hematol Oncol. 2011 Mar;33(2):89-92. doi: 10.1097/MPH.0b013e3181ff78ce. J Pediatr Hematol Oncol. 2011. PMID: 21228718

8

Influence of iron regulating genes mutations on iron status in Egyptian patients with sickle cell disease.

Abdel Rahman HA, Abou-Elew HH, El-Shorbagy RM, Fawzy R, Youssry I. Abdel Rahman HA, et al. Among authors: youssry i. Ann Clin Lab Sci. 2014 Summer;44(3):304-9. Ann Clin Lab Sci. 2014. PMID: 25117103

9

Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.

Abd-Elmawla MA, Rizk SM, Youssry I, Shaheen AA. Abd-Elmawla MA, et al. Among authors: youssry i. PLoS One. 2016 May 17;11(5):e0155070. doi: 10.1371/journal.pone.0155070. eCollection 2016. PLoS One. 2016. PMID: 27187171 Free PMC article.

10

Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.

Youssry I, Soliman N, Ghamrawy M, Samy RM, Nasr A, Abdel Mohsen M, ElShahaat M, Bou Fakhredin R, Taher A. Youssry I, et al. Ann Hematol. 2017 Apr;96(4):597-603. doi: 10.1007/s00277-017-2925-x. Epub 2017 Feb 7. Ann Hematol. 2017. PMID: 28168351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page